Related references
Note: Only part of the references are listed.Elevation of Fatty Acid-Binding Protein 4 Is Predisposed by Family History of Hypertension and Contributes to Blood Pressure Elevation
Hideki Ota et al.
AMERICAN JOURNAL OF HYPERTENSION (2012)
Circulating Adipocyte Fatty Acid-Binding Protein Levels and Cardiovascular Morbidity and Mortality in Patients With Coronary Heart Disease A 10-year Prospective Study
Maximilian von Eynatten et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Impact of Insulin Resistance on Silent and Ongoing Myocardial Damage in Normal Subjects: The Takahata Study
Taro Narumi et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Serum Fatty Acid-Binding Protein 4 Is a Predictor of Cardiovascular Events in End-Stage Renal Disease
Masato Furuhashi et al.
PLOS ONE (2011)
Lipid Chaperones and Metabolic Inflammation
Masato Furuhashi et al.
INTERNATIONAL JOURNAL OF INFLAMMATION (2011)
Relation of Plasma Fatty Acid Binding Proteins 4 and 5 With the Metabolic Syndrome, Inflammation and Coronary Calcium in Patients With Type-2 Diabetes Mellitus
Roshanak Bagheri et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Revised Equations for Estimated GFR From Serum Creatinine in Japan
Seiichi Matsuo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2009)
Epidermal fatty-acid-binding protein: a new circulating biomarker associated with cardio-metabolic risk factors and carotid atherosclerosis
Dennis C. Y. Yeung et al.
EUROPEAN HEART JOURNAL (2008)
Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets
Masato Furuhashi et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Serum adipocyte fatty acid-binding protein as a new biomarker, predicting the development of type 2 diabetes - A 10-year prospective study in a Chinese cohort
Annette W. K. Tso et al.
DIABETES CARE (2007)
Circulating levels of heart-type fatty acid-binding protein in a general Japanese population - Effects of age, gender and Physiologic characteristics
Takeshi Niizeki et al.
CIRCULATION JOURNAL (2007)
Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis
D. C. Y. Yeung et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
Masato Furuhashi et al.
NATURE (2007)
Urinary fatty acid binding protein in renal disease
Atsuko Kamijo-Ikemori et al.
CLINICA CHIMICA ACTA (2006)
Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice
Elizabeth P. Newberry et al.
HEPATOLOGY (2006)
Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet
Menno Hoekstra et al.
JOURNAL OF LIPID RESEARCH (2006)
Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome
AM Xu et al.
CLINICAL CHEMISTRY (2006)
Liver fatty acid binding protein gene ablation potentiates hepatic cholesterol accumulation in cholesterol-fed female mice
GG Martin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Dexamethasone: Benefit and prejudice for patients undergoing on-pump coronary artery bypass grafting - A study on myocardial, pulmonary, renal, intestinal, and hepatic injury
AM Morariu et al.
CHEST (2005)
Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth
S Stan et al.
JOURNAL OF LIPID RESEARCH (2005)
Fatty acid-binding proteins as plasma markers of tissue injury
MMAL Pelsers et al.
CLINICA CHIMICA ACTA (2005)
Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes
K Maeda et al.
CELL METABOLISM (2005)
Utility of serum ratio of heart-type fatty acid-binding protein to myoglobin for cardiac damage regardless of renal dysfunction
M Furuhashi et al.
CIRCULATION JOURNAL (2004)
Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease
A Kamijo et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2004)
Decreased hepatic triglyceride accumulation and altered fatty acid uptake in mice with deletion of the liver fatty acid-binding protein gene
EP Newberry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Intestinal-type and liver-type fatty acid-binding protein in the intestine. Tissue distribution and clinical utility
MMAL Pelsers et al.
CLINICAL BIOCHEMISTRY (2003)
Decreased liver fatty acid binding capacity and altered liver lipid distribution in mice lacking the liver fatty acid-binding protein gene
GG Martin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of the fatty acid binding protein mal1 in obesity and insulin resistance
K Maeda et al.
DIABETES (2003)
Serum ratio of heart-type fatty acid-binding protein to myoglobin - A novel marker of cardiac damage and volume overload in hemodialysis patients
M Furuhashi et al.
NEPHRON CLINICAL PRACTICE (2003)
Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure
K Setsuta et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Analysis on the phenotype of E-FABP-gene knockout mice
Y Owada et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Plasma concentration of intestinal- and liver-FABP in neonates suffering from necrotizing enterocolitis and in healthy preterm neonates
F Guthmann et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2002)
Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
L Makowski et al.
NATURE MEDICINE (2001)
Share Paper
